$NVS
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$NVS
Novartis AG
$NVSNYSEHealthcareMega-Cap
Novartis develops and manufactures innovative medicines across cardiovascular, immunology, neuroscience, and oncology.
Market Cap
$205.0B
Revenue (TTM)
$47.0B
+8.0%
Net Income (TTM)
$11.0B
+12.0%
EPS (TTM)
$5.30
P/E Ratio
18.0
Dividend Yield
3.0%
52-Week Range
$85-$115
Beta
0.42
Dimension Scores
Fundamental
76Technical
68Sentiment
72Risk / Reward
76Momentum
66Financial Health
Profitability
81strong
Growth
69moderate
Liquidity
84strong
Solvency
78strong
Efficiency
74strong
Valuation, technical analysis, investment thesis, risk assessment and more for $NVS
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.